Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory M Cote

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
The Lancet. Oncology|October 9, 2020
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket studyMrinal Gounder, Patrick Schöffski, Robin L Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2024
A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient TumorsJ Andrew Livingston, Jean-Yves Blay, Jonathan Trent, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 6, 2026
Combination of Lurbinectedin plus Irinotecan: Preclinical and Early Clinical Results in Relapsed Small Cell Lung Cancer PatientsSantiago Ponce, Miguel Ruiz-Torres, Alejandro Falcón, et al.
Nature Communications|April 28, 2022
EWSR1-ATF1 dependent 3D connectivity regulates oncogenic and differentiation programs in Clear Cell SarcomaEmely Möller, Viviane Praz, Sanalkumar Rajendran, et al.
Cell Reports|April 16, 2020
LIN28B Underlies the Pathogenesis of a Subclass of Ewing SarcomaTugba Keskin, Arnaud Bakaric, Patricia Waszyk, et al.
Cell Reports|April 3, 2020
LIN28B Underlies the Pathogenesis of a Subclass of Ewing Sarcoma LIN28B Control of EWS-FLI1 StabilityTugba Keskin, Arnaud Bakaric, Patricia Waszyk, et al.
Pediatric Blood & Cancer|June 22, 2023
The NIH pediatric/young adult chordoma clinic and natural history study: Making advances in a very rare tumorLiny John, Hannah Smith, Maran Ilanchezhian, et al.
Neuro-Oncology|December 19, 2025
Prospective, Randomized Dose Escalation Trial with Proton-Based Radiation for Skull Base and Cervical Spine Chondrosarcomas: 30-year outcomes from PROG 85-26Myrsini Ioakeim-Ioannidou, Beow Y Yeap, Zainab O Soetan, et al.
Cancer|October 28, 2022
Complete tumor necrosis after neoadjuvant chemotherapy defines good responders in patients with Ewing sarcomaSantiago A Lozano-Calderón, Jose Ignacio Albergo, Olivier Q Groot, et al.
The New England Journal of Medicine|March 8, 2023
Nirogacestat, a γ-Secretase Inhibitor for Desmoid TumorsMrinal Gounder, Ravin Ratan, Thierry Alcindor, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
The Lancet. Oncology|October 9, 2020
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket studyMrinal Gounder, Patrick Schöffski, Robin L Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2024
A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient TumorsJ Andrew Livingston, Jean-Yves Blay, Jonathan Trent, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 6, 2026
Combination of Lurbinectedin plus Irinotecan: Preclinical and Early Clinical Results in Relapsed Small Cell Lung Cancer PatientsSantiago Ponce, Miguel Ruiz-Torres, Alejandro Falcón, et al.
Nature Communications|April 28, 2022
EWSR1-ATF1 dependent 3D connectivity regulates oncogenic and differentiation programs in Clear Cell SarcomaEmely Möller, Viviane Praz, Sanalkumar Rajendran, et al.
Cell Reports|April 16, 2020
LIN28B Underlies the Pathogenesis of a Subclass of Ewing SarcomaTugba Keskin, Arnaud Bakaric, Patricia Waszyk, et al.
Cell Reports|April 3, 2020
LIN28B Underlies the Pathogenesis of a Subclass of Ewing Sarcoma LIN28B Control of EWS-FLI1 StabilityTugba Keskin, Arnaud Bakaric, Patricia Waszyk, et al.
Pediatric Blood & Cancer|June 22, 2023
The NIH pediatric/young adult chordoma clinic and natural history study: Making advances in a very rare tumorLiny John, Hannah Smith, Maran Ilanchezhian, et al.
Neuro-Oncology|December 19, 2025
Prospective, Randomized Dose Escalation Trial with Proton-Based Radiation for Skull Base and Cervical Spine Chondrosarcomas: 30-year outcomes from PROG 85-26Myrsini Ioakeim-Ioannidou, Beow Y Yeap, Zainab O Soetan, et al.
Cancer|October 28, 2022
Complete tumor necrosis after neoadjuvant chemotherapy defines good responders in patients with Ewing sarcomaSantiago A Lozano-Calderón, Jose Ignacio Albergo, Olivier Q Groot, et al.
The New England Journal of Medicine|March 8, 2023
Nirogacestat, a γ-Secretase Inhibitor for Desmoid TumorsMrinal Gounder, Ravin Ratan, Thierry Alcindor, et al.
Pageof 10